VXRT logoVXRT
Vaxart Inc

75,163
Loading...
Loading...
Vaxart, Inc. operates as a clinical-stage biotechnology company, which engages in the development of oral recombinant vaccines based on its Vector-Adjuvant-Antigen Standardized Technology oral vaccine platform. Its investigational vaccines are administered using a room temperature-stable tablet, rather than by injection. It is developing prophylactic vaccine candidates that target a range of infectious diseases, including SARS-CoV-2, norovirus, seasonal influenza and respiratory syncytial virus (RSV). The company was founded by Sean Tucker in March 2004 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
115

Frequently Asked Questions

What is Market Cap of Vaxart Inc?
What is the 52-week high for Vaxart Inc?
What is the 52-week low for Vaxart Inc?
What is Vaxart Inc stock price today?
What was Vaxart Inc stock price yesterday?
What is the PE ratio of Vaxart Inc?
What is the Price-to-Book ratio of Vaxart Inc?
What is the 50-day moving average of Vaxart Inc?
How many employess does Vaxart Inc has?

Latest VXRT News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.